Publicaciones (24) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis

    Journal of Neuroimmunology

  2. Antimicrobial susceptibility of Listeria monocytogenes isolated from food and clinical cases in Navarra, Spain

    Journal of Food Protection, Vol. 70, Núm. 10, pp. 2402-2406

  3. Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis

    Vaccine, Vol. 25, Núm. 15, pp. 2858-2862

  4. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles

    Vaccine, Vol. 25, Núm. 48, pp. 8123-8132

  5. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

    Expert Opinion on Drug Delivery, Vol. 4, Núm. 6, pp. 677-688

  6. Biotechnological war against biofilms. Could phages mean the end of device-related infections?

    International Journal of Artificial Organs, Vol. 30, Núm. 9, pp. 805-812

  7. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence

    Infection and Immunity, Vol. 75, Núm. 10, pp. 4867-4874

  8. Comparison of multiple-locus variable-number tandem-repeat analysis with other PCR-based methods for typing Brucella suis isolates

    Journal of Clinical Microbiology, Vol. 45, Núm. 12, pp. 4070-4072

  9. Enterovirus 75, un nuevo virus patógeno en nuestro medio

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 9, pp. 566-569

  10. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

  11. Gamma interferon loaded onto albumin nanoparticles: In vitro and in vivo activities against Brucella abortus

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1310-1314

  12. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens

    Vaccine, Vol. 25, Núm. 29, pp. 5263-5271

  13. Intradermal immunization with ovalbumin-loaded poly-ε-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

    Clinical and Experimental Allergy, Vol. 37, Núm. 2, pp. 287-295

  14. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: Thermodynamic, biophysical and microbiological analysis

    Biochemical Journal, Vol. 406, Núm. 2, pp. 297-307

  15. Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo

    International Journal of Cancer, Vol. 121, Núm. 6, pp. 1197-1204

  16. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)- glucosamine

    Infection and Immunity, Vol. 75, Núm. 7, pp. 3406-3413

  17. Nanoparticles as adjuvant-vectors for vaccination

    Nanoparticulate Drug Delivery Systems (CRC Press), pp. 317-325

  18. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

    Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464

  19. Poly(D,L-lactide-coglycolide) particles containing gentamicin: Pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1185-1190

  20. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 18, pp. 7528-7533